Clinical Trials
5
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Phase 3
4 (100.0%)Novaferon in Non-hospitalized Adult Patients With Mild COVID-19
Phase 3
- Conditions
- Covid19
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Genova Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT05172037
- Locations
- π―π΅
Tokyo Shinagawa Hospital, Tokyo, Japan
Novaferon for COVID-19 Treatment Trial (NCTT-005)
Phase 3
- Conditions
- Covid19
- First Posted Date
- 2021-01-13
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Genova Inc.
- Target Recruit Count
- 385
- Registration Number
- NCT04708158
- Locations
- π―π΅
Chiba Aoba Municipal Hospital, Chiba, Japan
π―π΅Kamagaya General Hospital, Chiba, Japan
π―π΅NHO Chiba Medical Center, Chiba, Japan
Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19
Phase 3
- Conditions
- Covid19
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- Genova Inc.
- Target Recruit Count
- 914
- Registration Number
- NCT04669015
- Locations
- π¦π·
Hospital Interzonal General de Agudos Dr Jose Penna, Bahia Blanca, Argentina
π¦π·CEMIC, Ciudad Autonoma Buenos Aires, Argentina
π¦π·Clinica Adventista Belgrano, Ciudad Autonoma Buenos Aires, Argentina
News
No news found